Reporte del uso de infliximab en psoriasis generalizada y resistente / Use of infl iximab in refractory and extended psoriasis report
Folia dermatol. peru
;
18(1): 32-36, ene.-abr. 2007. ilus
Article
in Spanish
| LILACS, LIPECS
| ID: lil-503250
RESUMEN
La psoriasis es una enfermedad inflamatoria hiperproliferativa de causa desconocida y multifactorial. Es la primera causa de consulta y hospitalización en el Servicio de Dermatología del Hospital Nacional Guillermo Almenara Irigoyen (HNGAI). Se presenta un caso de tratamiento exitoso con infliximab en un paciente con psoriasis extensa y resistente a terapia convencional.
ABSTRACT
Psoriasis is an infl ammatory hiperproliferative disease of unknown cause and polygenic factors. Is the most common disease among patientsrequiring hospitalization in Dermatology Service of Guillermo Almenara Irigoyen Hospital (GAIH). Here we report on the successful treatmentwith infl iximab in a patient with refractory and extensive psoriasis.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Patients
/
Psoriasis
/
Antibodies, Monoclonal
Limits:
Animals
/
Humans
Language:
Spanish
Journal:
Folia dermatol. peru
Year:
2007
Type:
Article
Institution/Affiliation country:
Essalud/PE
Similar
MEDLINE
...
LILACS
LIS